Icrucumab (FLT1/ VEGFR-1) - Research Grade Biosimilar
Selected Variant
10-451
Size: 0.1 mg
Product Specifications
Background
Icrucumab is under investigation in clinical trial NCT01111604 (A Study of IMC-1121B or IMC-18F1 in Colorectal Cancer) .
Immunogen
Homo sapiens / FLT1/ VEGFR-1 [Homo sapiens]
Clonality
Recombinant Monoclonal
Conjugation
Unconjugated
Type
Primary Antibodies, Biosimilars
Source
CHO cells
Field of Research
Cancer
Purification
>95%
Concentration
Batch dependent
Buffer
PBS buffer pH7.5
Modification
None
Shipping Conditions
Blue Ice
Storage Conditions
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 ˚ C for 1-2 weeks. Store at -20 ˚ C for 12 months. Store at -80 ˚ C for long term storage.
Fragment
IgG1-kappa
NCBI Organism
Homo sapiens
Other Product Names
18F1, IMC-18F1, LY3012212
Price
Sign In for Pricing
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNUB1967-500 1x 500 µL
Thyroglobulin (Thyroidal Cell Marker) (rTGB24), 0.2mg/mL
Sign In for Pricing
View Details 
BNC743777-100 1x 100 µL
Human Lambda Light Chain (B-Cell Marker) (rLLC/3777), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC943269-100 1x 100 µL
Endoglin / CD105 (Angiogenesis Marker) (ENG/3269), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC471223-500 1x 500 µL
Chromogranin A (LK2H10 + PHE5 + CGA414), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740198-100 1x 100 µL
Cytokeratin 18 (DA7), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC042353-100 1x 100 µL
Calcineurin A / PPP3CA (CALNA/2353), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details